Related Experiment Videos
Thrombospondin-1 (TSP-1) and Survivin (S) expression in non-Hogkin's lymphomas
Semra Paydas1, Melek Ergin, Seyda Erdogan
1Department of Oncology, Cukurova University Faculty of Medicine, Turkey. sepay@cu.edu.tr
Abstract:
Survivin (S) is a member of inhibitor of apoptosis family (IAP) and is expressed in the majority of malignant tumors but undetectable in normal differentiated adult tissues. S is an encouraging target for cancer therapy. TSP-1 is a multifunctional protein regulating cell growth, motility and apoptosis in both physiological and pathological conditions. The role of TSP-1 in cancer progression remains controversial. We aimed to determine the pathogenetic and prognostic role of TSP-1 and S in non-Hodgkin's lymphomas (NHL). S and TSP-1 expressions were looked for in 177 cases with NHL. S was found to be positive in 94 of the cases (53%). TSP-1 was found to be positive in 31 of the cases (17.5%). There was a strong association between S and TSP-1 and also aggressive histology with S and TSP-1. The overall survival (OS) times were longer in cases without S expression than cases with S expression (p=0.0514). Although the OS was shorter in TSP-1 expressing cases as compared with TSP-1 (-) cases, difference was not significant (p=0.2428). In conclusion, S and TSP-1 expressions were detected in 53 and 17.5% of the cases with NHL, and are associated with aggressive histology and shorter OS.
Insights
Survivin (S) and Thrombospondin-1 (TSP-1) are linked to aggressive non-Hodgkin's lymphomas (NHL). Higher expression of S and TSP-1 correlates with poorer overall survival in NHL patients.
Area of Science:
- Oncology
- Molecular Biology
- Hematology
Background:
- Survivin (S), an inhibitor of apoptosis protein (IAP), is upregulated in many cancers but not normal tissues, making it a promising therapeutic target.
- Thrombospondin-1 (TSP-1) is a multifunctional protein with a debated role in cancer progression, influencing cell growth, motility, and apoptosis.
- Non-Hodgkin's lymphomas (NHL) represent a diverse group of lymphoid malignancies with varying prognoses.
Purpose of the Study:
- To investigate the pathogenetic and prognostic significance of Survivin (S) and Thrombospondin-1 (TSP-1) expression in non-Hodgkin's lymphomas (NHL).
- To correlate the expression levels of S and TSP-1 with histological subtypes and overall survival in NHL patients.
Main Methods:
- Immunohistochemical analysis of Survivin (S) and Thrombospondin-1 (TSP-1) expression in 177 NHL patient samples.
- Statistical analysis to determine associations between protein expression, histological grade, and overall survival (OS).
Main Results:
- Survivin (S) was expressed in 53% of NHL cases, and TSP-1 in 17.5% of cases.
- A significant association was observed between S and TSP-1 expression and aggressive NHL histology.
- Patients with S expression had shorter overall survival (OS) times (p=0.0514), while TSP-1 expression showed a trend towards shorter OS (p=0.2428).
Conclusions:
- Survivin (S) and TSP-1 are expressed in a subset of NHL and are associated with aggressive disease.
- S expression is linked to poorer overall survival in NHL, suggesting its potential as a prognostic marker.
- These findings highlight the potential roles of S and TSP-1 in NHL pathogenesis and prognosis, warranting further investigation for therapeutic strategies.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Abnormal Proliferation
Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...